• Tues news: Prostate cancer trials to watch. Merck’s subcutaneous Keytruda. Apellis sees positive in Astellas CRL. Future of Medicare price negotiations. JNJ psoriasis results. See more on our front page

Patterson Layoffs

That is one of the main reasons you are seeing a lot of the Patterson ES jumping ship. Granted, the ones that haven't already been forced out. Even after cutting commissions by about 25% Patterson would still refuse to pick up any of the travel expenses for vip trips, regardless of which mfg was involved. At least they quit forcing trips to Adec after that exclusive ended.